228 related articles for article (PubMed ID: 8394365)
1. Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor.
Teicher BA; Holden SA; Khandakar V; Herman TS
J Cancer Res Clin Oncol; 1993; 119(11):645-51. PubMed ID: 8394365
[TBL] [Abstract][Full Text] [Related]
2. Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum(II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivo.
Boscia RE; Korbut T; Holden SA; Ara G; Teicher BA
Int J Cancer; 1993 Jan; 53(1):118-23. PubMed ID: 8416195
[TBL] [Abstract][Full Text] [Related]
3. Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo.
Epelbaum R; Teicher BA; Holden SA; Ara G; Varshney A; Herman TS
Eur J Cancer; 1992; 28A(4-5):794-800. PubMed ID: 1524897
[TBL] [Abstract][Full Text] [Related]
4. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Korbut TT
Cancer Res; 1990 Jul; 50(13):3826-31. PubMed ID: 2354434
[TBL] [Abstract][Full Text] [Related]
5. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
Herman TS; Teicher BA; Coleman CN
Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
[TBL] [Abstract][Full Text] [Related]
6. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
7. Interaction of ionizing radiation with topotecan in two human tumor cell lines.
Marchesini R; Colombo A; Caserini C; Perego P; Supino R; Capranico G; Tronconi M; Zunino F
Int J Cancer; 1996 May; 66(3):342-6. PubMed ID: 8621255
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I.
Kim JH; Kim SH; Kolozsvary A; Khil MS
Int J Radiat Oncol Biol Phys; 1992; 22(3):515-8. PubMed ID: 1310495
[TBL] [Abstract][Full Text] [Related]
9. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
Holden SA; Teicher BA; Herman TS
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
[TBL] [Abstract][Full Text] [Related]
10. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).
Mattern MR; Hofmann GA; McCabe FL; Johnson RK
Cancer Res; 1991 Nov; 51(21):5813-6. PubMed ID: 1657371
[TBL] [Abstract][Full Text] [Related]
11. Combined modality therapy with bleomycin, hyperthermia, and radiation.
Teicher BA; Herman TS; Holden SA
Cancer Res; 1988 Nov; 48(22):6291-7. PubMed ID: 2460220
[TBL] [Abstract][Full Text] [Related]
12. Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma.
Herman TS; Teicher BA
Cancer Res; 1988 May; 48(10):2693-7. PubMed ID: 3359430
[TBL] [Abstract][Full Text] [Related]
13. Interaction of PtCl4(Fast Black)2 with hyperthermia.
Teicher BA; Herman TS; Pfeffer MR; Alvarez Sotomayor E; Khandekar VS
Cancer Res; 1989 Nov; 49(22):6208-13. PubMed ID: 2804969
[TBL] [Abstract][Full Text] [Related]
14. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
[TBL] [Abstract][Full Text] [Related]
15. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues.
Emerson DL; Besterman JM; Brown HR; Evans MG; Leitner PP; Luzzio MJ; Shaffer JE; Sternbach DD; Uehling D; Vuong A
Cancer Res; 1995 Feb; 55(3):603-9. PubMed ID: 7834631
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo.
Kusumoto T; Holden SA; Ara G; Teicher BA
Int J Hyperthermia; 1995; 11(4):575-86. PubMed ID: 7594810
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.
Teicher BA; Holden SA; Herman TS; Epelbaum R; Pardee AB; Dezube B
Anticancer Res; 1991; 11(4):1555-60. PubMed ID: 1746913
[TBL] [Abstract][Full Text] [Related]
18. Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia.
Herman TS; Teicher BA; Pfeffer MR; Khandekar VS; Alvarez Sotomayor E
Cancer Chemother Pharmacol; 1990; 26(2):127-34. PubMed ID: 2347038
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
Kirichenko AV; Rich TA; Newman RA; Travis EL
Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors.
Kurtzberg LS; Battle T; Rouleau C; Bagley RG; Agata N; Yao M; Schmid S; Roth S; Crawford J; Krumbholz R; Ewesuedo R; Yu XJ; Wang F; Lavoie EJ; Teicher BA
Mol Cancer Ther; 2008 Oct; 7(10):3212-22. PubMed ID: 18852125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
